Heteroaryl compounds as 5-ht4 receptor ligands

The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds...

Full description

Saved in:
Bibliographic Details
Main Authors NIROGI RAMAKRISHNA, MOHAMMED ABDUL RASHEED, SHINDE ANIL KARBHARI, JAYARAJAN PRADEEP, YARLGADDA SURESH, ROAYALLEY PRAVEEN KUMAR, PATNALA SRIRAMACHANDRA MURTHY, BHYRAPUNENI GOPINADH, RAVULA JYOTHSNA, RAVELLA SRINIVASA RAO, JASTI VENKATESWARLU, KAMBHAMPATI RAMASASTRI
Format Patent
LanguageChinese
English
Published 30.10.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors.
Bibliography:Application Number: CN201280009072